2nd Quarter - Amendment
GEPHARDT GROUP GOVERNMENT AFFAIRS for COUNCIL FOR AMERICAN MEDICAL INNOVATION (CAMI)
Income
$140,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2011 | $140,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 21, 2011 | $140,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
medical innovation; access to medicines; FDA reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| CAITLIN DONOVAN | Legislative Correspondent, Rep. Ackerman |
| RICHARD GEPHARDT | Member of Congress |
| ANDREA KING | Staff Director, Rep. Gephardt |
Medical/Disease Research/Clinical Labs MED
medical innovation; access to medicines; FDA reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| CAITLIN DONOVAN | Legislative Correspondent, Rep. Ackerman |
| RICHARD GEPHARDT | Member of Congress |
| ANDREA KING | Staff Director, Rep. Gephardt |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.